Effect of Oliceridine Combined with Sufentanil on Patient-Controlled Intravenous Analgesia in Elderly Patients After Laparoscopic Radical Resection of Rectal Cancer: A Prospective Randomized Controlled Study
Drug Design, Development and Therapy · 2025-11 · Volume 19 · 10033-10043
DOI: 10.2147/dddt.s553848 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Drug Design, Development and Therapy, 2025-11. Verfasst von Yifu Tian und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Tianjin Cancer Hospital Airport Hospital, National Clinical Research Center for Cancer, Airport Economic Zone, Tianjin,…. Hauptthemen laut MEDLINE: Sufentanil, Analgesia, Patient-Controlled, Laparoscopy, Postoperative Pain. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Background
Currently, there is no report on the efficacy evaluation of oliceridine in patient - controlled intravenous analgesia (PCIA) for elderly patients after surgery. This study aims to investigate the analgesic effect of oliceridine combined with sufentanil under the PCIA treatment mode.
Methods
A total of 112 patients were randomly assigned to the sufentanil group (Group S), the oliceridine group (Group O), and the oliceridine + sufentanil group (Group Z). Patients in Group S received 2.0 µg/kg sufentanil; those in Group O received 0.35 mg/kg oliceridine; and patients in Group Z received 1.0 µg/kg sufentanil + 0.35 mg/kg oliceridine. The visual analogue scale (VAS) for pain at rest and during activity within 48 hours after surgery were used as the primary outcome indicators. The secondary observation indicators include the Athens Insomnia Scale (AIS) score for postoperative sleep quality, the number of times the analgesia pump is pressed within 48 hours after surgery, the situation of rescue analgesia, and the occurrence of adverse events.
Results
Among the 112 patients analyzed, the combination of oliceridine and sufentanil significantly reduced the VAS scores for pain at rest and during activity within 48 hours after surgery (p < 0.01), and had the lowest incidence rates of postoperative nausea and vomiting (PONV) and respiratory depression (p < 0.05). Meanwhile, this combination regimen significantly decreased the AIS scores (P < 0.001), the times of analgesia pump pressing (p < 0.01), the times of rescue analgesia (p < 0.05), and the rescue analgesia rate (P < 0.001).
Conclusion
In the pain management after laparoscopic radical resection of rectal cancer in elderly patients, oliceridine combined with sufentanil provides the best analgesic effect and has the lowest incidence of adverse reactions associated with opioids.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Tianjin Cancer Hospital Airport Hospital, National Clinical Research Center for Cancer, Airport Economic Zone, Tianjin, 300308, People's Repulic of China.
Zitieren
APA
Tian, Y., Hu, J., Pan, H., Bai, G., Zhang, Z., & Zhang, P. (2025). Effect of Oliceridine Combined with Sufentanil on Patient-Controlled Intravenous Analgesia in Elderly Patients After Laparoscopic Radical Resection of Rectal Cancer: A Prospective Randomized Controlled Study. Drug Design, Development and Therapy, Volume 19, 10033-10043. https://doi.org/10.2147/dddt.s553848
Vancouver
Tian Y, Hu J, Pan H, Bai G, Zhang Z, Zhang P. Effect of Oliceridine Combined with Sufentanil on Patient-Controlled Intravenous Analgesia in Elderly Patients After Laparoscopic Radical Resection of Rectal Cancer: A Prospective Randomized Controlled Study. Drug Design, Development and Therapy. 2025;Volume 19:10033-10043. doi:10.2147/dddt.s553848
BibTeX
@article{Tian2025,
author = {Tian, Yifu and Hu, Jiarui and Pan, Haitao and Bai, Guang and Zhang, Zhao and Zhang, Peng},
title = {Effect of Oliceridine Combined with Sufentanil on Patient-Controlled Intravenous Analgesia in Elderly Patients After Laparoscopic Radical Resection of Rectal Cancer: A Prospective Randomized Controlled Study},
journal = {Drug Design, Development and Therapy},
year = {2025},
volume = {Volume 19},
pages = {10033--10043},
doi = {10.2147/dddt.s553848}
}
EUVIMED